T1	Measurement 14 26	Ph (BCR/ABL)
T2	Value 27 35	positive
R1	Has_value Arg1:T1 Arg2:T2	
T3	Qualifier 36 43	de novo
R2	Has_qualifier Arg1:T1 Arg2:T3	
T4	Value 44 54	< 55 years
T5	Person 55 58	old
R3	Has_value Arg1:T5 Arg2:T4	
T6	Non-representable 59 128	(it is advisable to include patients over 55 years LAL07OPH protocol)
T7	Measurement 131 149	Performance status
T8	Value 150 153	0-2
R4	Has_value Arg1:T7 Arg2:T8	
T10	Condition 255 286	functional impairment of organs
T9	Non-representable 154 235	(Appendix B) may include patients with performance status > 2 attributable to LAL
T11	Negation 247 254	without
T12	Measurement 304 319	total bilirubin
T13	Measurement 321 324	AST
T14	Measurement 326 329	ALT
T15	Measurement 331 338	alfa-GT
T16	Measurement 343 363	alkaline phosphatase
T17	Value 364 407	less than 3 times the upper limit of normal
R5	Has_negation Arg1:T10 Arg2:T11	
T18	Scope 304 363	total bilirubin, AST, ALT, alfa-GT and alkaline phosphatase
R6	Has_value Arg1:T18 Arg2:T17	
T19	Scope 304 407	total bilirubin, AST, ALT, alfa-GT and alkaline phosphatase less than 3 times the upper limit of normal
T20	Scope 247 286	without functional impairment of organs
T21	Measurement 435 451	serum creatinine
T22	Value 452 461	< 2 mg/dL
T23	Measurement 465 485	clearance creatinine
T24	Value 486 497	> 30 ml/min
T25	Non-representable 498 541	(except renal function attributable to LAL)
T26	Measurement 542 558	cardiac function
T27	Value 572 578	normal
R8	Has_value Arg1:T26 Arg2:T27	
R9	Has_value Arg1:T23 Arg2:T24	
R10	Has_value Arg1:T21 Arg2:T22	
*	OR T21 T23
T28	Measurement 580 594	ventricular EF
T29	Value 595 600	> 50%
R7	Has_value Arg1:T28 Arg2:T29	
T30	Negation 602 612	absence of
T31	Condition 613 647	severe chronic respiratory disease
R11	Has_negation Arg1:T31 Arg2:T30	
T32	Scope 542 578	cardiac function (Appendix B) normal
T33	Scope 580 600	ventricular EF > 50%
R12	Subsumes Arg1:T32 Arg2:T33	
T34	Non-representable 649 805	In the event that alterations are secondary to the disease is at the discretion of the investigator to determine if the patient can be included in the trial
T35	Scope 304 648	total bilirubin, AST, ALT, alfa-GT and alkaline phosphatase less than 3 times the upper limit of normal laboratory renal function: serum creatinine < 2 mg/dL or clearance creatinine > 30 ml/min (except renal function attributable to LAL) cardiac function (Appendix B) normal: ventricular EF > 50%, absence of severe chronic respiratory disease.
R13	Subsumes Arg1:T20 Arg2:T35	
